Assessing the Case Against Direct-to-Consumer Drug Advertisements

Authors

Neeraj Sood (ORCID: https://orcid.org/0000-0001-9805-213X)
Abby Alpert

Institutions

University of Southern California (US)
National Bureau of Economic Research (US)
University of Pennsylvania (US)
Philadelphia University (US)

Publication Details

Journal: JAMA Health Forum
Published: 2025-11-14
DOI: https://doi.org/10.1001/jamahealthforum.2025.5325
Citations: 1
Primary Topic: Pharmaceutical industry and healthcare
Type: article
Field-Weighted Citation Impact: 1.56

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Assessing the Case Against Direct-to-Consumer Drug Advertisements

Neeraj Sood, Abby Alpert

Nov 14, 2025

1 citations

JAMA Health Forum

Pharmaceutical industry and healthcare

1.56

article

Assessing the Case Against Direct-to-Consumer Drug Advertisements

Neeraj Sood, Abby Alpert

November 14, 2025article en

1 citations

Abstract

No abstract available for this paper.

JAMA Health ForumVol. 6(11)

University of Southern California (US), National Bureau of Economic Research (US), University of Pennsylvania (US), Philadelphia University (US)

Openalex Percentile: Top 14%

Pharmaceutical industry and healthcare

1.56

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Assessing the Case Against Direct-to-Consumer Drug Advertisements — Neeraj Sood, Abby Alpert · JAMA Health Forum (2025) | TGRS Research Map | TGRS